Digital Memory Album on Psychosocial Wellbeing among People with Dementia Living in Community – A Single Blind Randomised Controlled Trial
- Conditions
- DementiaCognitive ImpairmentNeurological - Dementias
- Registration Number
- ACTRN12622000269730
- Lead Sponsor
- niversity Kebangsaan Malaysia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
•Participants aged 60 years old and above, ambulatory and community dwelling with a diagnosis of dementia according to DSM-5 by a psychogeriatrician.
•The rating of the Clinical Dementia Rating (Hughes et al., 1982) should be stage 1 (mild) or stage 2 (moderate).
•Participants should have sufficient abilities to speak, write and read in Malay language.
•Participants and relatives (caregivers) were willing to participate and consent for the study.
•Participants must have a relative, close friend, or care staff member who is willing to participate in tasks which require an informant perspective and give necessary additional life history of participant.
Participants were excluded from the study if they had a history of psychosis based on medical record, presence of psychiatric diagnosis (based on DSM-5) other than dementia (major neurocognitive disorders), severe physical condition or uncorrected sensory problem e.g. vision or hearing and severe dementia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of Life-Alzheimer’s Disease (QOL-AD) (Logsdon, Gibbons, McCurry, & Teri, 2002)[Baseline, at 8 weeks (at the end of intervention, primary endpoint) and at 14 weeks (follow-up from baseline)];Addenbrooke’s Cognitive Examination III (ACE-III) (Hsieh, Schubert, Hoon, Mioshi, & Hodges, 2013)[Baseline, at 8 weeks (at the end of intervention, primary endpoint) and at 14 weeks (follow-up from baseline)];Geriatric Depression Scale-Short Form (GDS-15) (Yesavage & Sheikh, 1986)[Baseline, at 8 weeks (at the end of intervention, primary endpoint) and at 14 weeks (follow-up from baseline)]
- Secondary Outcome Measures
Name Time Method